Author

Henrique Melo

Mount Sinai Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Anne‐Claude GingrasiD· 1 shared Arne Nedergaard KousholtiD· 1 shared Atina G. CotéiD· 1 shared Daniel DurocheriD· 1 shared Daniel R. TabetiD· 1 shared Dheva SetiaputraiD· 1 shared Diana Rubio-ContrerasiD· 1 shared Fernando Gómez-HerrerosiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Anne‐Claude GingrasORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genome-scale mapping of DNA damage suppressors identifies GNB1L as essential for ATM and ATR biogenesis

Yichao Zhao, Daniel R. Tabet, Diana Rubio-Contreras, Arne Nedergaard Kousholt, Jochen Weile, Henrique Melo, Lisa Hoeg, Atina G. Coté, Zhen‐Yuan Lin, Dheva Setiaputra, Jos Jonkers, Anne‐Claude Gingras, Fernando Gómez-Herreros, Frederick P. Roth, Daniel Durocher

The paper identifies 160 genes that suppress DNA damage in human cells through CRISPR/Cas9 screens, highlighting GNB1L's role in ATR biogenesis and its link to neuropsychiatric disorders.

bioRxiv · Sep 23, 2022 · PreprintMolecular Biology